Heart disease treatment pioneered in Surrey

Royal Surrey is one of a few hospitals across the world to be using the technology

A new treatment for patients with coronary artery disease is being pioneered by the Royal Surrey NHS Foundation Trust.

It has become the first NHS trust in the UK to introduce Medis-QFR (Quantitative Flow Ratio) technology, which provides a non-surgical assessment of the circulation of blood to a patient's heart.

The technology offers a non-interventional alternative procedure for patients requiring a diagnosis.

The introduction of the pioneering treatment follows the refurbishment of the trust's cardiac catheterisation laboratory more than a year ago.

Patients who have blocked or narrowed coronary arteries will receive a coronary angiogram that uses X-ray and special dye to show the blockage in the vessels of their heart.

However, a further invasive procedure is needed to assess if the narrowing is causing flow problems.

Dr Alvina Amin, clinical director for cardiology, said: "We are incredibly proud to be one of the first centres offering this advanced investigation.

"It highlights our unwavering commitment to advancing patient care through innovation.

"This milestone marks a significant continuation of our journey toward delivering the most advanced cardiology services available, setting new standards in patient care both nationally and internationally."

Follow BBC Surrey on Facebook, on X. Send your story ideas to [e-mail] or WhatsApp us on 08081 002250.